Besides pathogenesis, the literature suggests that AMPs may also represent good diagnostic candidates for the identification of a panel of biomarkers capable of identifying AD, especially from a salivary source, and thus potentially capable of cutting down the expensive and lengthy current diagnostic process of AD (Table 1). Here, ADSL is linked to Alzheimer disease.